Complementary and alternative medicine in the context of earlier diagnoses of Alzheimer's disease: opening the conversation to prepare ethical responses

Racine, Eric, Forlini, Cynthia, Aspler, John and Chandler, Jennifer (2016) Complementary and alternative medicine in the context of earlier diagnoses of Alzheimer's disease: opening the conversation to prepare ethical responses. Journal of Alzheimer's Disease, 51 1: 1-9. doi:10.3233/JAD-150534


Author Racine, Eric
Forlini, Cynthia
Aspler, John
Chandler, Jennifer
Title Complementary and alternative medicine in the context of earlier diagnoses of Alzheimer's disease: opening the conversation to prepare ethical responses
Journal name Journal of Alzheimer's Disease   Check publisher's open access policy
ISSN 1875-8908
1387-2877
Publication date 2016-02-27
Year available 2016
Sub-type Critical review of research, literature review, critical commentary
DOI 10.3233/JAD-150534
Open Access Status Not Open Access
Volume 51
Issue 1
Start page 1
End page 9
Total pages 9
Place of publication Amsterdam, Netherlands
Publisher I O S Press
Collection year 2017
Language eng
Abstract Preclinical Alzheimer's disease (AD), a newly proposed, actively researched, and hotly debated research-only diagnostic category, raises the prospect of an ethical dilemma: whether, and possibly how, to treat a disorder with no target symptoms. This proposed category rests on the detection of a number of biomarkers thought to provide evidence of AD pathophysiology years before any behavioral symptoms manifest. Faced with limited treatment options, patients and their relatives may come to consider complementary and alternative medicine (CAM) a viable option, albeit one with minimal supporting evidence. Accordingly, the hopes and needs of some preclinical patients and their relatives could further fuel market-oriented entrepreneurship for CAM. In this ethics review, we provide background and reflect on some ethical questions related to the roles of key stakeholders arising from the potential for CAM use in the context of a possible preclinical AD diagnosis.
Keyword Alzheimer's disease
Bioethics
Complementary therapies
Health policy
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Critical review of research, literature review, critical commentary
Collections: UQ Centre for Clinical Research Publications
HERDC Pre-Audit
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 1 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 1 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Tue, 22 Mar 2016, 00:38:44 EST by System User on behalf of Learning and Research Services (UQ Library)